Funding for this research was provided by:
Dagmar Marshalls Fond
Sundhedsvidenskabelige Fakultet, Aarhus Universitet
Aase og Ejnar Danielsens Fond
Sundhed, Region Midtjylland
Læge Søren Segel og Hustru Johanne Wiibroe Segels Forskningsfond
Fonden til Lægevidenskabens Fremme
Received: 28 June 2018
Accepted: 15 August 2019
First Online: 2 September 2019
Ethics approval and consent to participate
: The CONDISOX trial will be conducted in accordance with the ethical principles outlined in the latest version of the ‘Declaration of Helsinki’ and the ‘Guideline for Good Clinical Practice’ related to experiments on humans. The Central Denmark Region Committee on Biomedical Research Ethics and The Danish Health Authority have approved the study. The Medical Research Ethics Committees of the Amsterdam University Medical Centre has approved the Dutch part of the study. All the eligible women will have both written and oral information about the study methods, the aims of the research and the possible adverse events related to the interventions, and will give written informed consent prior to randomisation. The consent forms will be kept safe during the study period in accordance with Danish and Dutch legislation.
: The authors declare that they have no competing interests.